Durability of Response to SARS-CoV-2 BNT162b2 Vaccination in Patients on Active Anticancer Treatment
Noa Eliakim‐Raz, Amir Massarweh, Amos Stemmer, Salomon M. Stemmer
Abstract
This cohort study examines the durability of immune response from BNT162b2 vaccination for severe acute respiratory syndrome coronavirus 2 in patients with cancer vs healthy controls.
Topics & Concepts
MedicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VaccinationCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakMEDLINEVirologyInternal medicineOutbreakInfectious disease (medical specialty)LawDiseasePolitical scienceSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesVaccine Coverage and Hesitancy